We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVE icon
2026
Cenovus Energy
CVE
$55.6B
$446K ﹤0.01%
27,900
MDC
2027
DELISTED
M.D.C. Holdings, Inc.
MDC
$446K ﹤0.01%
20,651
+710
+4% +$14.5K
ALX
2028
Alexander's
ALX
$1.39B
$443K ﹤0.01%
1,080
FFIN icon
2029
First Financial Bankshares
FFIN
$5.01B
$443K ﹤0.01%
25,576
MSTR icon
2030
Strategy Inc
MSTR
$37.3B
$443K ﹤0.01%
26,060
FULT icon
2031
Fulton Financial
FULT
$4.67B
$442K ﹤0.01%
33,876
-10,900
-24% -$138K
WMC
2032
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$442K ﹤0.01%
2,992
DOC
2033
DELISTED
PHYSICIANS REALTY TRUST
DOC
$442K ﹤0.01%
28,800
+4,300
+18% +$71.3K
HTH icon
2034
Hilltop Holdings
HTH
$2.25B
$441K ﹤0.01%
18,298
CBU icon
2035
Community Bank
CBU
$3.43B
$439K ﹤0.01%
11,620
FFIC
2036
DELISTED
Flushing Financial
FFIC
$439K ﹤0.01%
20,875
PRI icon
2037
Primerica
PRI
$9.57B
$439K ﹤0.01%
9,618
SSB icon
2038
SouthState Bank Corp
SSB
$10.7B
$438K ﹤0.01%
5,759
CVSA
2039
Covista Inc
CVSA
$4.36B
$435K ﹤0.01%
14,500
OFLX icon
2040
Omega Flex
OFLX
$304M
$435K ﹤0.01%
11,540
-200
-2% -$6.27K
BOBE
2041
DELISTED
Bob Evans Farms, Inc.
BOBE
$434K ﹤0.01%
8,500
TIVO
2042
DELISTED
TIVO INC
TIVO
$433K ﹤0.01%
42,700
RTI
2043
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
$432K ﹤0.01%
13,700
-285,190
-95% -$10.3M
SAFM
2044
DELISTED
Sanderson Farms Inc
SAFM
$431K ﹤0.01%
5,740
FINL
2045
DELISTED
Finish Line
FINL
$430K ﹤0.01%
15,458
ZNGA
2046
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$429K ﹤0.01%
150,016
+1,100
+0.7% +$3.08K
BGS icon
2047
B&G Foods
BGS
$291M
$428K ﹤0.01%
15,000
+2,500
+20% +$75.1K
MTGE
2048
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$428K ﹤0.01%
26,754
+123
+0.5% +$2.16K
BAH icon
2049
Booz Allen Hamilton
BAH
$9.43B
$427K ﹤0.01%
16,900
MITT
2050
TPG Mortgage Investment Trust
MITT
$213M
$427K ﹤0.01%
8,233

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.